BG
NRC icon

Bahl & Gaynor’s NRC Health Common Stock NRC Stock Holding History

Bahl & Gaynor’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-44,168
Closed -$2.07M – 349
2021
Q1 		$2.07M Buy
44,168
+1,845
+4% +$89.7K 0.01% 229
2020
Q4 		$1.81M Buy
42,323
+139
+0.3% +$7.14K 0.01% 236
2020
Q3 		$2.08M Sell
42,184
-1,089
-3% -$60.3K 0.01% 221
2020
Q2 		$2.52M Buy
+43,273
New +$2.29M 0.02% 197
2013
Q3 		– Sell
-19,575
Closed -$352K – 370
2013
Q2 		$352K Buy
+19,575
New +$313K 0.01% 281

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bahl & Gaynor's NRC Position: Q2 2021 in Review

Bahl & Gaynor sold out of NRC Health Common Stock (NRC) in Q2 2021, closing a stake of 44,168 shares — an estimated $2.07M sold.

Bahl & Gaynor first reported a position in NRC in Q2 2013 and held it in 5 quarters. The position peaked at $2.52M in Q2 2020. 100 funds tracked by Wall St. Rank hold NRC as of Q2 2021.

  • Bahl & Gaynor reported no remaining NRC Health Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bahl & Gaynor sold 44,168 NRC Health Common Stock shares in Q2 2021, an estimated $2.07M.
  • Bahl & Gaynor first reported a position in NRC Health Common Stock in Q2 2013 and held it in 5 quarters.
  • Bahl & Gaynor's NRC Health Common Stock position peaked at $2.52M in Q2 2020.
  • 100 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2021.

Based on Bahl & Gaynor's 13F filing for Q2 2021, filed 6 Aug 2021.